Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2015Terapevticheskii arkhivOpen Access

Therapy for Burkitt’s lymphoma according to the BL-M-04 protocol: 12-year experience

View Full Paper
Ask AI
Bookmark
Share

Authors

ЕBЕ. А. BaryakhRussian Medical Academy of Continuous Professional EducationNTN. G. TyurinaP.A. Hertzen Moscow Oncology Research InstituteVVVladimir VorobyevLeningrad Regional Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Baryakh et al. (2015) studied this question.

synapsesocial.com/papers/6a8449664d02f4f0268d7936https://doi.org/10.17116/terarkh20158774-14
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis2014 · 12 citations
  2. 2Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial2014 · 299 citations
  3. 3Brief-Duration High-Intensity Chemotherapy for Patients With Small Noncleaved–Cell Lymphoma or FAB L3 Acute Lymphocytic Leukemia: Results of Cancer and Leukemia Group B Study 92512001 · 103 citations
  4. 4Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types).1986 · 117 citations
  5. 5High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program2013 · 49 citations